Electrical Stimulation Therapy for Nerve Injury After Arm Surgery
(PHINEST Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that Percutaneous Electrical Nerve Stimulation (PENS) and Transcutaneous Electrical Nerve Stimulation (TENS) have been effective in managing pain and aiding nerve regeneration in various conditions. These therapies use electrical currents to stimulate nerves, which can help reduce pain and promote healing.
12345Transcutaneous electrical nerve stimulation (TENS) is widely used for pain relief in various conditions and is considered safe for most people. It is a noninvasive method that delivers electrical currents through the skin to activate nerves, and while evidence on its effectiveness can be inconclusive, safety concerns are minimal.
45678Electrical stimulation therapy is unique because it uses low-frequency electrical currents to enhance nerve regeneration and functional recovery, which is not typically achieved with standard surgical treatments. This therapy can accelerate axon growth and improve nerve function, offering a novel approach compared to traditional methods that often result in incomplete recovery.
29101112Eligibility Criteria
This trial is for adults aged 18-80 with certain types of nerve injuries in the arm, who are candidates for surgery to fix these nerves. They must be able to give consent and not have severe heart issues or other conditions that would prevent surgery.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Intervention
Participants undergo surgical intervention for peripheral nerve injury, with the treatment group receiving a single 10-minute dose of electrical stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at multiple time points up to 18 months